Octagon Capital Advisors LP BBIO Holdings History
Octagon Capital Advisors LP's BridgeBio Pharma Inc Holding Summary
As of 2025-03-31, Octagon Capital Advisors LP held - shares of BridgeBio Pharma Inc(BBIO), totaling N/A. This investment constitutes 0% of their stock portfolio, and Octagon Capital Advisors LP now holds 0% of the outstanding BridgeBio Pharma Inc(BBIO) stock.
The initial trade took place in 2021Q2. And since then Octagon Capital Advisors LP has made 5 purchases of BBIO, at an average price of $34.55, for a total of 2.67 Mil shares. In addition, there have been 8 sales at an average price of $18.68 for 2.67 Mil shares. Based on historical transaction data and BBIO's current price of $46.19, Octagon Capital Advisors LP's estimated gain on his BBIO holdings is $-42.40 Mil, reflecting a -45.94% gain to date.
Octagon Capital Advisors LP BBIO ($46.19) Holding Chart
Octagon Capital Advisors LP BBIO ($46.19) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
